Clover Health Q3 net income swings to $6.44 million; Q3 total revenues rise 53% to $759.3 million

By Public Technologies
  • Clover Health swung to third-quarter 2026 net income of $6.44 million from a year-earlier loss.
  • Total revenues climbed 53% year-over-year to $759.3 million, while quarter-end Medicare Advantage membership rose 45% to 158,907.
  • The flagship PPO, representing approximately 98% of current membership, received a 5 Star rating for Payment Year 2028.
  • Full-year 2026 guidance increased to net income of $25 million-$35 million and total revenues of $2.97 billion-$3 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611041605PRIMZONEFULLFEED9870431) on November 04, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.